Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 27

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 27
---
6 and will be a pro rata dividend from and including the original issue date of the
Series B Preferred Stock to but excluding the January 31, 2026 payment date in the amount of $
per share. The first dividend will be paid on February 2, 2026 since January 31, 2026 is not a business day.

These cumulative cash dividends will accrue at a rate per annum equal
to % of the liquidation preference of $25.00 per share (equivalent to $
per share per annum) with respect to each dividend period from and including the original issue date. In the event that we issue additional
Series B Preferred Stock after the original issue date, dividends on such shares will accrue from the original issue date or the
most recent dividend payment date at which dividends were paid in full.

Dividends will be payable to holders of record
as of 5:00 p.m., New York time, on the related record date. The record dates for the Series B Preferred Stock are the January 15,
April 15, July 15 or October 15 immediately preceding the relevant dividend payment date (each, a “dividend record
date”). The term “business day” means any day, other than a Saturday or Sunday, that is neither a legal holiday nor
a day on which banking institutions are authorized or required by law or regulation to close in The City of New York.

A dividend period is the period from and including
a dividend payment date to, but excluding, the next dividend payment date or any earlier redemption date, except that the initial dividend
period will be the period from and including the original issue date of the Series B Preferred Stock to, but excluding the January 31,
2026 dividend payment date. Dividends payable on the Series B Preferred Stock will be computed on the basis of a 360-day year consisting
of twelve 30-day months and will be calculated from the original issue date.

Notwithstanding the foregoing, dividends on the
Series B Preferred Stock will accrue whether or not funds are legally available for the payment of those dividends, whether or not
we have earnings and whether or not those dividends are authorized. No interest, or sum in lieu of interest, will be payable in respect
of any dividend payment or payments on the Series B Preferred Stock which may be in arrears, and holders of the Series B Preferred
Stock will not be entitled to any dividends in excess of full cumulative dividends described above. Any dividend payment made